A NOVEL THERAPEUTIC STRATEGY TARGETING BACH1 FOR TRIPLE-NEGATIVE BREAST CANCER

$577,942FY2017Department of the ArmyDOD

University Of Chicago, Chicago IL

Investigators

View source on USAspending →